PGY2 ID Pharmacy Specialty Residency

Program Overview

The Stanford Antimicrobial Safety and Sustainability program is recognized as an Infectious Diseases Society of America (IDSA) Center of Excellence and a World Health Organization (WHO) Collaborating Centre for Antimicrobial Resistance and Stewardship. The residency program will offer the resident clinical training and mentorship through a variety of experiences in infectious diseases and antimicrobial stewardship.

In addition to clinical practice experiences, the PGY-2 ID resident will have the opportunity to participate in academic activities, which include an optional teaching certificate, precepting pharmacy residents/students, and providing didactic lectures to the Stanford Infectious Diseases Fellowship Program. The resident will also conduct a research project and engage in leadership development.

The SHC PGY-2 Infectious Diseases Residency Program is currently in Pre-Candidate status by the American Society of Health-System Pharmacists (ASHP).

Program Goal

The purpose of this residency program is to gain knowledge in infectious diseases pharmacotherapy and develop the skills needed to promote the safe and effective use of antimicrobials as a member of a multidisciplinary team.

  • Provide optimal clinical care to patients with infectious diseases
  • Function as an effective member of the healthcare team
  • Educate healthcare professionals, students, patients and the community about antimicrobials and antimicrobial resistance
  • Develop excellent written and verbal communication skills
  • Demonstrate time management and problem-solving skills
  • Become a leader within the pharmacy profession

Program Structure

The program follows the ASHP Residency Learning System and its goals and learning objectives are consistent with standards developed by ASHP.

Required Program Rotations

  • Orientation/Training (2 weeks)
  • Antimicrobial Stewardship – clinical focus (4 weeks)
  • General ID consult service (8 weeks)
  • Hematology/Oncology and BMT ID consult service (4 weeks)
  • Solid Organ Transplant ID consult service (4 weeks)
  • Critical Care ID consult service (4 weeks)
  • Antimicrobial stewardship – administrative focus (4 weeks)
  • Clinical Microbiology (4 weeks)

Elective Rotations

  • Pediatric ID (Stanford Children’s Health)
  • Hematology/Oncology
  • Bone Marrow Transplant
  • Critical Care – medical/surgical ICU
  • Solid Organ Transplant
  • HIV clinic
  • Emergency Medicine

Residency Requirements

  • Complete and present a longitudinal research project at a national conference
  • Complete and present findings of a quality improvement initiative at Stanford Health Care (SHC)
  • Development of an institutional clinical guideline or pathway
  • Participate in teaching activities with residents and/or students
  • Participate in SHC Antimicrobial Subcommittee
  • Present a Continuing Education lecture to peers
  • Staff approximately every 3-weeks



William Alegria, PharmD, BCIDP

William Alegria, Pharm.D., BCIDP graduated from Rosalind Franklin University of Medicine and Science in 2016. He then completed a pharmacy practice residency at the University of California, San Francisco and an infectious diseases specialty residency at the University of Michigan. Before joining the Stanford Antimicrobial Safety and Sustainability program, he worked at the University of California, San Francisco Medical Center as a clinical pharmacist in neurology and pediatric/adult infectious diseases. His professional interests include immunocompromised infectious diseases, gram negative resistance, and clinical outcomes research.

David Ha, PharmD, BCIDP

David Ha, PharmD, BCIDP graduated from the University of California, San Diego in 2012. He completed his PGY1 Acute Care pharmacy practice residency at UC San Diego Health in 2013 and PGY2 Infectious Diseases pharmacy practice residency at UC San Diego Health in 2014. Prior to joining Stanford Healthcare, he practiced at Pomona Valley Medical Center and the Keck Graduate Institute as clinical faculty and infectious diseases pharmacist. His professional interests include interdisciplinary collaboration, public and global health, and clinical research in the areas of antimicrobial stewardship, infectious diseases, and infection prevention.

Lina Meng, PharmD, BCCCP, BCIDP

Lina Meng, Pharm.D., BCCCP, BCIDP, graduated from University of California, San Diego. She completed her pharmacy practice residency at the University of California, San Francisco and a critical care residency at Stanford Health Care. She practiced in the medical/surgical/cardiothoracic ICU prior to joining the Stanford Antimicrobial Stewardship Team in 2015.  She is currently practicing as an ID Clinical Pharmacist with a research interest in antimicrobial stewardship interventions, particularly in critically ill patients.

Emily Mui, PharmD, BCIDP

Emily Mui, Pharm.D., BCIDP graduated from Northeastern University in 2008. She completed her pharmacy practice residency and Infectious Diseases specialty residency at Brigham and Women’s Hospital. Upon completion of residency, she practiced as a General Medicine Clinical Pharmacist before transitioning into her current role as an Antimicrobial Stewardship Clinical Pharmacist. 

Compensation & Benefits

The resident will receive a competitive annual stipend of approximately $83,000 with full benefits, including an excellent healthcare benefits package and 10 days of paid time off (PTO). In addition, the resident will receive educational leave and a stipend to attend and participate in various pharmacy or infectious diseases conferences such as the ASHP Midyear Clinical Meeting in December and Infectious Diseases Society of America (IDWeek) meeting in October.



Participation in our specialized residency in infectious diseases pharmacy practice requires a Pharm.D. degree from an ACPE-accredited college or school of pharmacy, completion of an ASHP-accredited PGY-1 residency program, and CA licensure/eligibility. All applicants must be enrolled in the ASHP Residency Match Program.  Applicant Agreements for participation in the Match can be downloaded from the Matching Program Web site at The National Matching Services (NMS) Code for the Stanford Infectious Diseases Residency is 625955.

Application Process

Interested applicants must complete ALL of the following:


  • Enrollment in the ASHP Residency Match Program
  • Submit the following required documents through PhORCAS
    1. Your personal statement outlining career goals, areas of interest and reasons for applying to the residency program at Stanford Health Care
    2. Your Curriculum Vitae
    3. Official School of Pharmacy transcript of records sent directly from the school
    4. Three references using the standardized template in PhORCAS submitted directly by the reference writer. 
    5. Complete the Stanford Health Care online application process:
      1. Access
      2. Create an account.
      3. Under "Search by Req #", enter "TBD" and click "Start Job Search".
      4. Follow the instructions on the website.
      5. Under the resume section, please attach your Curriculum Vitae.
      6. When finished, click submit.
    6. For consideration, the online application and all supporting documentations must be received by Tuesday, December 31, 2019.

    On-Site Interview

    After all application materials are reviewed, the candidate will be contacted for phone/video conference interview prior to a half-day on-site interview.  The candidate is required to give a 15-minute PowerPoint presentation.

    On-site interviews will be conducted in February 2020.


    Application Deadline

    The application deadline is Tuesday, December 31, 2019.

    NO applications will be accepted beyond this date.


    Program director: Lina Meng

    Program coordinator: David Ha